6756 — VIA Labs Income Statement
0.000.00%
Last trade - 00:00
- TWD11.48bn
- TWD10.12bn
- TWD2.04bn
- 81
- 17
- 13
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,586 | 1,970 | 3,367 | 2,955 | 2,035 |
Cost of Revenue | |||||
Gross Profit | 822 | 961 | 1,795 | 1,546 | 931 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,306 | 1,584 | 2,337 | 2,245 | 1,879 |
Operating Profit | 280 | 386 | 1,030 | 710 | 156 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 282 | 358 | 1,041 | 848 | 214 |
Provision for Income Taxes | |||||
Net Income After Taxes | 243 | 318 | 880 | 724 | 181 |
Net Income Before Extraordinary Items | |||||
Net Income | 243 | 318 | 880 | 724 | 181 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 243 | 318 | 880 | 724 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.83 | 5.04 | 12.5 | 10.2 | 2.57 |
Dividends per Share |